Collagen type I is the main organic constituent of the bone extracellular matrix and has been used for decades as scaffolding material in bone tissue engineering approaches when autografts are not feasible. Polymeric collagen can be easily isolated from various animal sources and can be processed in a great number of ways to manufacture biomaterials in the form of sponges, particles, or hydrogels, among others, for different applications. Despite its great biocompatibility and osteoconductivity, collagen type I also has some drawbacks, such as its high biodegradability, low mechanical strength, and lack of osteoinductive activity. Therefore, many attempts have been made to improve the collagen type I-based implants for bone tissue engineering. This review aims to summarize the current status of collagen type I as a biomaterial for bone tissue engineering, as well as to highlight some of the main efforts that have been made recently towards designing and producing collagen implants to improve bone regeneration.

No abstract

No abstract

The development of scaffolds mimicking native bone tissue composition and structure is a challenge in bone tissue engineering. 3D scaffolds with both an interconnected macropore structure and nanotextured surfaces are required. However, 3D scaffolds processed by microfabrication usually lack of nanotextured surface, while nanotextured materials generated by bottom-up nanofabrication are difficult to process conforming scaffolds having well interconnected microsized cavities. In this work, the processing of reticulated (macropore interconnected) structures using nanostructured precursors has been performed to improve the mechanical properties of the scaffolds. The application of a fibrillar collagen coating, using less than 1 wt% collagen per scaffold, has allow a significant increase of the compressive strength while preserving a high surface area and nanopore accessibility. Besides, the fibrillar nanostructured collagen coating promotes hydroxyapatite mineralization. Two different collagen-coating procedures are applied showing interesting differences in terms of mechanical performance.

Background: Gene therapy is a therapeutic possibility for retinitis pigmentosa (RP), in which therapeutic transgenes are currently delivered to the retina by adeno-associated viral vectors (AAVs). Although their safety and efficacy have been demonstrated in both clinical and preclinical settings, AAVs present some technical handicaps, such as limited cargo capacity and possible immunogenicity in repetitive doses. The development of alternative, non-viral delivery platforms like nanoparticles is of great interest to extend the application of gene therapy for RP. Methods: Amino-functionalized mesoporous silica-based nanoparticles (N-MSiNPs) were synthesized, physico-chemically characterized, and evaluated as gene delivery systems for human cells in vitro and for retinal cells in vivo. Transgene expression was evaluated by WB and immunofluorescence. The safety evaluation of mice subjected to subretinal injection was assessed by ophthalmological tests (electroretinogram, funduscopy, tomography, and optokinetic test). Results: N-MSiNPs delivered transgenes to human cells in vitro and to retinal cells in vivo. No adverse effects were detected for the integrity of the retinal tissue or the visual function of treated eyes. N-MSiNPs were able to deliver a therapeutic transgene candidate for RP, PRPF31, both in vitro and in vivo. Conclusions: N-MSiNPs are safe for retinal delivery and thus a potential alternative to viral vectors.

Abstract-In this work, hybrid scaffold materials composed of gelatin and Bioactive Glass (BG) have been fabricated. BG particulates in the ternary system SiO 2 -CaO-P 2 O 5 have been synthesized initially using the sol-gel method. The gelatin/BG scaffolds were shaped by a freeze-drying process obtaining homogeneous and reproducible final macroporous structures. BG particulates precursor and the final hybrid macroporous structures (scaffolds) were characterized using Field Emission Scanning Electron Microscopy (FE-SEM), Energy Dispersive X-ray Analysis (EDX), X-ray diffraction (XRD) and thermal analysis. Finally, the scaffolds were essayed in Simulated Body Fluid (SBF) in vitro showing a bioactive response.

No abstract

Human induced pluripotent stem cells (hiPSCs) represent the most promising biological material for regenerative medicine applications. In this work, a 3D solid nanofibrous matrix of defined composition (Colamigel-S) consisting of 97 wt % gelatin, 2.6 wt % atelocollagen, and 0.4 wt % laminin has been reproducibly processed and characterized and exhibits a homogeneous nanofibrillar network of high surface area, interconnected microcavities, and typical D-periodic collagen fibril nanostructural features. The purpose of the study was to test the performance of Colamigel-S as substrate for in vitro hiPSCs culture, finding that these cells efficiently attach and grow keeping their characteristic stem morphology and undifferentiated state.